HomeRegistrationPresentationsFacultyRefer a ColleagueCurrent Webcast


Session 1: Setting the scene

Where did we leave off in 2008? Conclusions from the 8th International Symposium

Professor Graeme Russ
Queen Elizabeth Hospital, Adelaide, Australia

Immunoregulation and tolerance

Professor Mohamed H. Sayegh
Harvard Medical School, Boston, USA

Session 2: Reviewing the latest clinical evidence

New approaches to De Novo immunosuppression and steroid elimination

Professor Yvon Lebranchu
University Hospital of Tours, France

Optimizing early De Novo immunosuppression with sirolimus – experience in the USA

Dr. Matthew R. Weir
University of Maryland Hospital, Baltimore, Maryland, USA

Session 3: mTOR: effects and side effects

mTOR and autosomal dominant polycystic kidney disease

Professor Rudolf P. Wüthrich
University Hospital, Zürich, Switzerland

mTOR and cancer

Professor Edward K. Geissler
University of Regensburg, Germany

mTor and diabetes -- what does the current evidence tell us?

Professor Josep M. Campistol
Hospital Clinic, University of Barcelona, Spain

Regression of left ventricular hypertrophy in kidney transplant recipients – the potential role of mTOR

Dr. Ernesto Paoletti
San Martino University Hospital, Genoa, Italy

Session 4: The clinical perspectives to take home

Workshop feedback and conclusions


Professor Josep M. Campistol
Dr. Fritz Diekmann
Dr. Stuart M. Flechner
Professor Peter Friend
Professor Dr. Gert Mayer
Dr. Rainer Oberbauer
Professor Graeme Russ
Dr. Matthew R. Weir

Closing remarks and conclusions

Dr. Stuart M. Flechner
Cleveland Clinic, Lerner College of Medicine, Cleveland, Ohio, USA